Janux Therapeutics Inc (JANX) — Financial Flexibility Index
Janux Therapeutics Inc (JANX) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-12.06 Million (operating CF $-12.34 Million minus capex $273.00K) represents 0% of total liabilities ($86.69 Million). Also explore how fast is Janux Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Janux Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Janux Therapeutics Inc across 7 annual periods. Check Janux Therapeutics Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Janux Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Janux Therapeutics Inc. For the full company profile including market capitalisation, see Janux Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.60x | $-81.19 Million | $-82.23 Million | $50.70 Million | ▼ -42.7% |
| 2024 | -1.12x | $-43.45 Million | $-43.81 Million | $38.73 Million | ▲ +17.0% |
| 2023 | -1.35x | $-48.73 Million | $-50.58 Million | $36.06 Million | ▼ -60.3% |
| 2022 | -0.84x | $-36.48 Million | $-42.92 Million | $43.27 Million | ▲ +26.6% |
| 2021 | -1.15x | $-15.49 Million | $-16.98 Million | $13.50 Million | ▼ -1126.9% |
| 2020 | -0.09x | $-2.89 Million | $-4.37 Million | $30.86 Million | ▲ +65.6% |
| 2019 | -0.27x | $-2.35 Million | $-3.83 Million | $8.62 Million | — |